Cetera Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,966
| Closed | -$233K | – | 1688 |
|
|
2022
Q4 | $233K | Buy |
2,966
+104
| +4% | +$8.17K | ﹤0.01% | 1364 |
|
|
2022
Q3 | $204K | Sell |
2,862
-233
| -8% | -$16.6K | 0.01% | 1139 |
|
|
2022
Q2 | $232K | Sell |
3,095
-199
| -6% | -$14.9K | 0.01% | 1164 |
|
|
2022
Q1 | $262K | Sell |
3,294
-312
| -9% | -$24.8K | 0.01% | 1169 |
|
|
2021
Q4 | $293K | Sell |
3,606
-3,362
| -48% | -$273K | 0.01% | 1130 |
|
|
2021
Q3 | $539K | Buy |
6,968
+2,647
| +61% | +$205K | 0.01% | 856 |
|
|
2021
Q2 | $348K | Buy |
4,321
+1
| +0% | +$81 | 0.01% | 984 |
|
|
2021
Q1 | $341K | Buy |
4,320
+496
| +13% | +$39.2K | 0.01% | 898 |
|
|
2020
Q4 | $273K | Buy |
3,824
+317
| +9% | +$22.6K | 0.01% | 859 |
|
|
2020
Q3 | $224K | Buy |
3,507
+50
| +1% | +$3.19K | 0.01% | 843 |
|
|
2020
Q2 | $224K | Buy |
+3,457
| New | +$224K | 0.01% | 809 |
|
|
2019
Q2 | – | Sell |
-434
| Closed | -$28K | – | 1179 |
|
|
2019
Q1 | $28K | Buy |
+434
| New | +$28K | ﹤0.01% | 1044 |
|
|
2015
Q3 | – | Sell |
-2,564
| Closed | -$203K | – | 732 |
|
|
2015
Q2 | $203K | Sell |
2,564
-2,404
| -48% | -$190K | 0.02% | 652 |
|
|
2015
Q1 | $378K | Hold |
4,968
| – | – | 0.03% | 443 |
|
|
2014
Q4 | $332K | Buy |
4,968
+1,500
| +43% | +$100K | 0.03% | 458 |
|
|
2014
Q3 | $221K | Sell |
3,468
-400
| -10% | -$25.5K | 0.02% | 518 |
|
|
2014
Q2 | $236K | Buy |
+3,868
| New | +$236K | 0.03% | 499 |
|